Avalo Therapeutics, Inc. (AVTX): SCHEDULE 13G filed May 29, 2026

Form type
SCHEDULE 13G
Filing date
May 29, 2026
Accession number
0001172661-26-002447
Filer
Avalo Therapeutics, Inc. (CIK 1534120)